Image

Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer

Investigating a Type of Blood Test and a Blood Marker in Pancreatic Cancer

Recruiting
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer. It looks at the neutrophil-to-lymphocyte ratio (NLR) and CA 19.9 levels before surgery to understand more about the condition.

The study evaluates if these markers can help identify perineural invasion, which is a factor in the disease's progression.

  • Who can participate: Eligible participants are those diagnosed with adenocarcinoma who have undergone surgical removal of the tumor. Individuals with other cancer types or incomplete data are not eligible.
  • Study details: Participants will have their blood tested to calculate a type of blood test and a blood marker before and after any neoadjuvant therapy to study their potential as markers for perineural invasion.
Print
Study details
    Pancreatic Cancer
    Adult
    Perineural Invasion
    Neutrophil-to-Lymphocyte Ratio
    CA 19.9

NCT06747481

University of Las Palmas de Gran Canaria

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.